EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PRKN ‐Mediated Ubiquitin‐Proteasome Degradation of METTL3 Promotes Cellular Senescence

Liping Chen iD, Canfeng Zhang, Yuanlong Ge, Haoxian Zhou, Shenglong Yang, Wenjing Wei, Qinghua Zhou, Kaizhen Xiao, Guangyu Huang, Xiaocui Li, Jia Wang, Jinping Zheng und 3 weitere

Aging Cell · 2026

DOI: 10.1111/acel.70347 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, 2026. Verfasst von Liping Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: The Center for Medical Research, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, P. R. China. Hauptthemen laut MEDLINE: Cellular Senescence, Methyltransferases, Proteasome Endopeptidase Complex, Ubiquitin. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Guangxi Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

N6‐methyladenosine (m6A) methylation, a dynamic and reversible modification of eukaryotic mRNAs, plays critical roles in diverse cellular processes. Although METTL3‐mediated m6A deposition has been implicated in cellular senescence, the mechanisms controlling METTL3 stability and activity during senescence remain poorly defined. Here, we demonstrate that both m6A levels and METTL3 protein abundance are significantly reduced in replication‐induced and stress‐induced senescence models. METTL3 depletion promotes senescence by inducing telomere dysfunction via diminished expression of shelterin components TRF2 and POT1. Mechanistically, we identify PRKN (Parkin) as a senescence‐associated E3 ubiquitin ligase that promotes METTL3 proteasomal degradation through K48‐linked polyubiquitination at lysine 164. Genetic PRKN inhibition in pre‐senescent cells rescues METTL3 expression, restores TRF2/POT1 levels, reduces telomere dysfunction‐induced foci (TIFs), and attenuates senescence‐associated β‐galactosidase (SA‐β‐gal) activity. Crucially, PRKN overexpression accelerates telomere dysfunction and senescence in wild‐type METTL3‐expressing cells but not in cells expressing the ubiquitination‐resistant K164R METTL3 mutant. Our findings establish METTL3 ubiquitination as a pivotal regulator of telomere integrity and senescence progression, unveiling a therapeutic target for age‐related pathologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescenceMethyltransferasesProteasome Endopeptidase ComplexUbiquitinUbiquitin-Protein LigasesHumansUbiquitinationProteolysisTelomere

Stichwörter der Autor:innen

METTL3PRKNm6Asenescencetelomere

Substanzen

MethyltransferasesProteasome Endopeptidase ComplexUbiquitinMETTL3 protein, humanUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • The Center for Medical Research, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, P. R. China.
  • Guangxi Key Laboratory of Intelligent Precision Medicine, The First People's Hospital of Nanning, Nanning, Guangxi, P. R. China.
  • Center for Translational Medicine, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, P. R. China.
  • Key Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, Department of Developmental & Regenerative Medicine, College of Life Science and Technology, Jinan Universi…
  • Department of Cardiology, Guangdong Provincial Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, P. R. China.
  • Key Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine and the First Affiliated Hospital, Jinan University, Guangzhou, Guangdong, P. R. China.

ORCID-Profile: Liping Chen, Zhenyu Ju

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Guangxi Natural Science Foundation
  • Research Startup Foundation of Nanning First People's Hospital
  • National Key Research and Development Program of China
  • Natural Science Foundation of Guangxi Zhuang Autonomous Region

Zitieren

APA

Chen, L., Zhang, C., Ge, Y., Zhou, H., Yang, S., Wei, W., Zhou, Q., Xiao, K., Huang, G., Li, X., Wang, J., Zheng, J., Gu, R., Ju, Z., & Wu, S. (2026). PRKN ‐Mediated Ubiquitin‐Proteasome Degradation of METTL3 Promotes Cellular Senescence. Aging Cell. https://doi.org/10.1111/acel.70347

Vancouver

Chen L, Zhang C, Ge Y, Zhou H, Yang S, Wei W, et al. PRKN ‐Mediated Ubiquitin‐Proteasome Degradation of METTL3 Promotes Cellular Senescence. Aging Cell. 2026. doi:10.1111/acel.70347

BibTeX
@article{Chen2026,
  author = {Chen, Liping and Zhang, Canfeng and Ge, Yuanlong and Zhou, Haoxian and Yang, Shenglong and Wei, Wenjing and Zhou, Qinghua and Xiao, Kaizhen and Huang, Guangyu and Li, Xiaocui and Wang, Jia and Zheng, Jinping and Gu, Ronghe and Ju, Zhenyu and Wu, Shu},
  title = {PRKN ‐Mediated Ubiquitin‐Proteasome Degradation of METTL3 Promotes Cellular Senescence},
  journal = {Aging Cell},
  year = {2026},
  doi = {10.1111/acel.70347}
}
Kostenlos starten →